Global ophthalmic drugs market is anticipated to show a robust growth with an impressive CAGR in the forecast years, 2022-2026. The market growth attributes to the growing number of eye diseases and advancing pharmaceuticals and drugs. Moreover, consumers are more aware of the eye-related diseases and advancing technologies that would further accelerate the global ophthalmic drugs market in the upcoming five years. Diseases like diabetic retinopathy, macular degeneration, and presbyopia are rapidly spreading among the global population and thereby supporting the growth of the global ophthalmic drugs market in the next five years. The global ophthalmic drugs market was drastically affected due to recent COVID-19 pandemic situation. The pharmaceutical sector was dedicated completely to finding the vaccines and cure for coronavirus spread. Although recent advancement in the prevalence of eye infections and vision related diseases have enticed the pharmaceutical companies to develop more efficient and effective drugs and thus aiding the growth of the global ophthalmic drugs market in the future five years until 2026.

The global ophthalmic drugs market is segmented by drug class, indication, product type, dosage form, route of administration, distribution channel, competitional landscape, and regional distribution. Based on drug class, the market is further bifurcated into anti-inflammatory drugs, anti-infection drugs, anti-allergic drugs, anti-glaucoma drugs, and others. Anti-glaucoma drugs are anticipated to hold the largest revenue shares of the market and assert its dominance over the segment in the next five years, on the account of increasing number of patient suffering from loss of vision. One of the major reasons of loss of vision is glaucoma. Increasing instances of glaucoma is driving the growth of the anti-glaucoma drugs and thus supporting the growth of the global ophthalmic drugs market. Anti-infection drugs are expected to hold significant shares of the market. The growth can be attributed to rising cases of eye infection due to increasing cases of COVID-19 virus and its variants. The evolving virus is causing severe damages and the anti-infection drugs are anticipated overcome the infection thereby supporting the growth of the market until 2026.

Holding the major shares of the global ophthalmic drugs market are AbbVie Inc. (Allergan), Bausch Health Companies Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Hoya Corporation, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Alcon Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Merck & Co., Inc., Coherus Biosciences, Inc., among others. Market players are actively involved in the research and technological development in the pharmaceuticals and drugs department. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through Ophthalmic Drugs. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global ophthalmic drugs market from 2016 to 2019.
  • To estimate and forecast the market size of global ophthalmic drugs market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast global ophthalmic drugs market based on drug class, indication, product type, dosage form, route of administration, distribution channel, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global ophthalmic drugs market.
  • To identify drivers and challenges for global ophthalmic drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global ophthalmic drugs market.
  • To identify and analyze the profile of leading players operating in global ophthalmic drugs market.
  • To identify key sustainable strategies adopted by market players in global ophthalmic drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global Ophthalmic Drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributers and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to ophthalmic drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global ophthalmic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Ophthalmic Drugs Market, By Drug Class:
    • Anti-Inflammatory Drugs
    • Anti-Infection Drugs
    • Anti-Allergic Drugs
    • Anti-Glaucoma Drugs
    • Others
  • Global Ophthalmic Drugs Market, By Indication:
    • Dry Eye
    • Eye Allergy
    • Glaucoma
    • Eye Infection
    • Others
  • Global Ophthalmic Drugs Market, By Product Type:
    • OTC Drugs
    • Prescription Drugs
  • Global Ophthalmic Drugs Market, By Dosage Form:
    • Gels
    • Ointments
    • Eye Solutions
    • Eye Drops
    • Tablets & Capsules
  • Global Ophthalmic Drugs Market, By Route of Administration:
    • Topical
    • Ocular
    • Systemic
  • Global Ophthalmic Drugs Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Ophthalmic Drugs Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Belgium
      • Sweden
      • Switzerland
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Singapore
      • Indonesia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Qatar
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global ophthalmic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Ophthalmic Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Voice of Customer

4.    Impact of COVID-19 on Global Ophthalmic Drugs Market

5.    Executive Summary

6.    Ophthalmic Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Class (Anti-Inflammatory Drugs, Anti-Infection Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others)

6.2.2.     By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Others)

6.2.3.     By Product Type (OTC Drugs v/s Prescription Drugs)

6.2.4.     By Dosage Form (Gels, Ointments, Eye Solutions, Eye Drops, Tablets &Capsules)

6.2.5.     By Route of Administration (Topical, Ocular, Systemic)

6.2.6.     By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

6.2.7.     By Company (2020)

6.2.8.     By Region

6.3.  Product Market Map

7.    North America Ophthalmic Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Drug Class

7.2.2.     By Indication

7.2.3.     By Product Type

7.2.4.     By Dosage Form

7.2.5.     By Route of Administration

7.2.6.     By Distribution Channel

7.2.7.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Ophthalmic Drugs Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Drug Class

7.3.1.2.2.             By Indication

7.3.1.2.3.             By Product Type

7.3.1.2.4.             By Dosage Form

7.3.1.2.5.             By Route of Administration

7.3.1.2.6.             By Distribution Channel

7.3.2.     Canada Ophthalmic Drugs Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Drug Class

7.3.2.2.2.             By Indication

7.3.2.2.3.             By Product Type

7.3.2.2.4.             By Dosage Form

7.3.2.2.5.             By Route of Administration

7.3.2.2.6.             By Distribution Channel

7.3.3.     Mexico Ophthalmic Drugs Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Drug Class

7.3.3.2.2.             By Indication

7.3.3.2.3.             By Product Type

7.3.3.2.4.             By Dosage Form

7.3.3.2.5.             By Route of Administration

7.3.3.2.6.             By Distribution Channel

8.    Europe Ophthalmic Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Drug Class

8.2.2.     By Indication

8.2.3.     By Product Type

8.2.4.     By Dosage Form

8.2.5.     By Route of Administration

8.2.6.     By Distribution Channel

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Ophthalmic Drugs Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Drug Class

8.3.1.2.2.             By Indication

8.3.1.2.3.             By Product Type

8.3.1.2.4.             By Dosage Form

8.3.1.2.5.             By Route of Administration

8.3.1.2.6.             By Distribution Channel

8.3.2.     United Kingdom Ophthalmic Drugs Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Drug Class

8.3.2.2.2.             By Indication

8.3.2.2.3.             By Product Type

8.3.2.2.4.             By Dosage Form

8.3.2.2.5.             By Route of Administration

8.3.2.2.6.             By Distribution Channel

8.3.3.     France Ophthalmic Drugs Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Drug Class

8.3.3.2.2.             By Indication

8.3.3.2.3.             By Product Type

8.3.3.2.4.             By Dosage Form

8.3.3.2.5.             By Route of Administration

8.3.3.2.6.             By Distribution Channel

8.3.4.     Italy Ophthalmic Drugs Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Drug Class

8.3.4.2.2.             By Indication

8.3.4.2.3.             By Product Type

8.3.4.2.4.             By Dosage Form

8.3.4.2.5.             By Route of Administration

8.3.4.2.6.             By Distribution Channel

8.3.5.     Spain Ophthalmic Drugs Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Drug Class

8.3.5.2.2.             By Indication

8.3.5.2.3.             By Product Type

8.3.5.2.4.             By Dosage Form

8.3.5.2.5.             By Route of Administration

8.3.5.2.6.             By Distribution Channel

8.3.6.     Belgium Ophthalmic Drugs Market Outlook

8.3.6.1.         Market Size & Forecast

8.3.6.1.1.             By Value

8.3.6.2.         Market Share & Forecast

8.3.6.2.1.             By Drug Class

8.3.6.2.2.             By Indication

8.3.6.2.3.             By Product Type

8.3.6.2.4.             By Dosage Form

8.3.6.2.5.             By Route of Administration

8.3.6.2.6.             By Distribution Channel

8.3.7.     Sweden Ophthalmic Drugs Market Outlook

8.3.7.1.         Market Size & Forecast

8.3.7.1.1.             By Value

8.3.7.2.         Market Share & Forecast

8.3.7.2.1.             By Drug Class

8.3.7.2.2.             By Indication

8.3.7.2.3.             By Product Type

8.3.7.2.4.             By Dosage Form

8.3.7.2.5.             By Route of Administration

8.3.7.2.6.             By Distribution Channel

8.3.8.     Switzerland Ophthalmic Drugs Market Outlook

8.3.8.1.         Market Size & Forecast

8.3.8.1.1.             By Value

8.3.8.2.         Market Share & Forecast

8.3.8.2.1.             By Drug Class

8.3.8.2.2.             By Indication

8.3.8.2.3.             By Product Type

8.3.8.2.4.             By Dosage Form

8.3.8.2.5.             By Route of Administration

8.3.8.2.6.             By Distribution Channel

9.    Asia-Pacific Ophthalmic Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Drug Class

9.2.2.     By Indication

9.2.3.     By Product Type

9.2.4.     By Dosage Form

9.2.5.     By Route of Administration

9.2.6.     By Distribution Channel

9.2.7.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     Japan Ophthalmic Drugs Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Drug Class

9.3.1.2.2.             By Indication

9.3.1.2.3.             By Product Type

9.3.1.2.4.             By Dosage Form

9.3.1.2.5.             By Route of Administration

9.3.1.2.6.             By Distribution Channel

9.3.2.     China Ophthalmic Drugs Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Drug Class

9.3.2.2.2.             By Indication

9.3.2.2.3.             By Product Type

9.3.2.2.4.             By Dosage Form

9.3.2.2.5.             By Route of Administration

9.3.2.2.6.             By Distribution Channel

9.3.3.     India Ophthalmic Drugs Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Drug Class

9.3.3.2.2.             By Indication

9.3.3.2.3.             By Product Type

9.3.3.2.4.             By Dosage Form

9.3.3.2.5.             By Route of Administration

9.3.3.2.6.             By Distribution Channel

9.3.4.     South Korea Ophthalmic Drugs Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Drug Class

9.3.4.2.2.             By Indication

9.3.4.2.3.             By Product Type

9.3.4.2.4.             By Dosage Form

9.3.4.2.5.             By Route of Administration

9.3.4.2.6.             By Distribution Channel

9.3.5.     Australia Ophthalmic Drugs Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Drug Class

9.3.5.2.2.             By Indication

9.3.5.2.3.             By Product Type

9.3.5.2.4.             By Dosage Form

9.3.5.2.5.             By Route of Administration

9.3.5.2.6.             By Distribution Channel

9.3.6.     Singapore Ophthalmic Drugs Market Outlook

9.3.6.1.         Market Size & Forecast

9.3.6.1.1.             By Value

9.3.6.2.         Market Share & Forecast

9.3.6.2.1.             By Drug Class

9.3.6.2.2.             By Indication

9.3.6.2.3.             By Product Type

9.3.6.2.4.             By Dosage Form

9.3.6.2.5.             By Route of Administration

9.3.6.2.6.             By Distribution Channel

9.3.7.     Indonesia Ophthalmic Drugs Market Outlook

9.3.7.1.         Market Size & Forecast

9.3.7.1.1.             By Value

9.3.7.2.         Market Share & Forecast

9.3.7.2.1.             By Drug Class

9.3.7.2.2.             By Indication

9.3.7.2.3.             By Product Type

9.3.7.2.4.             By Dosage Form

9.3.7.2.5.             By Route of Administration

9.3.7.2.6.             By Distribution Channel

10.  South America Ophthalmic Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Drug Class

10.2.2.  By Indication

10.2.3.  By Product Type

10.2.4.  By Dosage Form

10.2.5.  By Route of Administration

10.2.6.  By Distribution Channel

10.2.7.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Ophthalmic Drugs Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Drug Class

10.3.1.2.2.           By Indication

10.3.1.2.3.           By Product Type

10.3.1.2.4.           By Dosage Form

10.3.1.2.5.           By Route of Administration

10.3.1.2.6.           By Distribution Channel

10.3.2.  Argentina Ophthalmic Drugs Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Drug Class

10.3.2.2.2.           By Indication

10.3.2.2.3.           By Product Type

10.3.2.2.4.           By Dosage Form

10.3.2.2.5.           By Route of Administration